Relevant research is published every day. Finding it shouldn't be hard. Latest findings from PubMed, bioRxiv, and clinical trial registries — curated by teams at Coimbra, Cambridge, and iMed.ULisboa.
Transforming the body's own cells into functioning neurons through epigenetic editing techniques that unlock the brain's capacity for self-repair.
View latest papers →How cell metabolism shapes brain-immune interactions, with a focus on new therapeutic approaches for MS and other CNS disorders.
View latest papers →The role of inflammation in the emergence or progression of neurodevelopmental and neurodegenerative disorders.
View latest papers →Find recruiting studies across conditions linked to brain regeneration.
Alzheimer's Disease is the most common cause of dementia, gradually impairing memory, thinking, and behaviour. Trials in this area investigate ways to slow or stop disease progression, clear amyloid and tau deposits, and protect or restore cognitive function.
View trials →Multiple Sclerosis (MS) is a chronic disease of the central nervous system in which the immune system attacks the myelin sheath that protects nerve fibres.
View trials →Parkinson's Disease, ALS, and other conditions are being evaluated for inclusion. Contact us to suggest a condition.
Updates, milestones, and announcements.
Brain Regeneration grew out of Gregory-MS, an observatory for Multiple Sclerosis research built in 2021. Learn how it works, who funds it, and what principles guide the curation.